As of June 18, 2026, Pfizer's top three insider holders are Frank A Damelio (Executive Vice President, 555.94K shares), Albert Bourla (Chairman Ceo, 388.67K shares), Mikael Dolsten (President Rd, 321.73K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Frank A Damelio | Executive Vice President | 555,941 | 0 | 01 Mar, 2022 |
| Ronald E Blaylock | - | 27,707 | 0 | 14 Feb, 2025 |
| William R Jr Carapezzi | Executive Vice President | 38,146 | 0 | 13 May, 2022 |
| Scott Gottlieb | - | 10,000 | 0 | 31 Oct, 2024 |
| David M Denton | Chief Financial Officer Evp | 37,919 | 0 | 03 Jun, 2024 |
| Mikael Dolsten | President Rd | 321,729 | 0 | 29 Feb, 2024 |
| Lidia Fonseca | Executive Vice President | 46,455 | 0 | 27 Feb, 2026 |
| Douglas M Lankler | Executive Vice President | 163,177 | 0 | 25 Feb, 2026 |
| John D Young | Group President | 312,704 | 0 | 12 Nov, 2021 |
| Rady A Johnson | Executive Vice President | 97,153 | 0 | 27 Feb, 2024 |
| Albert Bourla | Chairman Ceo | 388,671 | 0 | 27 Feb, 2026 |
| Alexander R Mackenzie | Executive Vice President | 87,280 | 0 | 06 Dec, 2021 |
| Angela Hwang | President, Global Biopharma | 29,778 | 0 | 28 Feb, 2023 |
| Jennifer B. Damico | Svp Controller | 32,934 | 0 | 05 Mar, 2026 |
| Payal Sahni | Executive Vice President | 27,667 | 0 | 27 Feb, 2026 |
| Aamir Malik | Executive Vice President | 29,548 | 0 | 03 Sep, 2024 |
| Michael Mcdermott | Executive Vice President | 74,308 | 0 | 27 Feb, 2026 |
| William Pao | Executive Vice President | 97,765 | 0 | 03 Apr, 2023 |
| Christoffel Boshoff | President, Rd | 161,379 | 0 | 27 Feb, 2026 |
| Germay Alexandre De | Executive Vice President | 74,377 | 0 | 28 Feb, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 15 Apr, 2026 | Albert Bourla | Phantom Stock Units SSP | A | 22 | $27.19 | 760,070 | D | A |
| 14 Apr, 2026 | Albert Bourla | Phantom Stock Units SSP | A | 911 | $27.11 | 760,090 | D | A |
| 31 Mar, 2026 | Albert Bourla | Phantom Stock Units SSP | A | 21 | $28.08 | 759,049 | D | A |
| 27 Mar, 2026 | James C Smith | Phantom Stock Units | A | 1,664 | $27.04 | 170,425 | D | A |
| 27 Mar, 2026 | James C Smith | Phantom Stock Units | A | 1,664 | $27.04 | 170,425 | D | A |
| 27 Mar, 2026 | James Quincey | Phantom Stock Units | A | 1,433 | $27.04 | 77,318 | D | A |
| 27 Mar, 2026 | Cyrus Taraporevala | Phantom Stock Units | A | 1,387 | $27.04 | 27,140 | D | A |
| 27 Mar, 2026 | James Quincey | Phantom Stock Units | A | 1,433 | $27.04 | 77,318 | D | A |
| 27 Mar, 2026 | James C Smith | Phantom Stock Units | A | 1,664 | $27.04 | 170,425 | D | A |
| 27 Mar, 2026 | Cyrus Taraporevala | Phantom Stock Units | A | 1,387 | $27.04 | 27,140 | D | A |
| 27 Mar, 2026 | James C Smith | Phantom Stock Units | A | 1,664 | $27.04 | 170,425 | D | A |
| 27 Mar, 2026 | James Quincey | Phantom Stock Units | A | 1,433 | $27.04 | 77,318 | D | A |
| 27 Mar, 2026 | Cyrus Taraporevala | Phantom Stock Units | A | 1,387 | $27.04 | 27,140 | D | A |
| 27 Mar, 2026 | James C Smith | Phantom Stock Units | A | 1,664 | $27.04 | 170,425 | D | A |
| 27 Mar, 2026 | James Quincey | Phantom Stock Units | A | 1,433 | $27.04 | 77,318 | D | A |
| 27 Mar, 2026 | James Quincey | Phantom Stock Units | A | 1,433 | $27.04 | 77,318 | D | A |
| 27 Mar, 2026 | Joseph Echevarria | Phantom Stock Units | A | 1,710 | $27.04 | 153,398 | D | A |
| 27 Mar, 2026 | Cyrus Taraporevala | Phantom Stock Units | A | 1,387 | $27.04 | 27,140 | D | A |
| 27 Mar, 2026 | Cyrus Taraporevala | Phantom Stock Units | A | 1,387 | $27.04 | 27,140 | D | A |
| 27 Mar, 2026 | Shantanu Narayen | Phantom Stock Units | A | 1,849 | $27.04 | 187,925 | D | A |